MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
Use this MGNX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MGNX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MGNX SEC filings page. Lician reads the product cache first so this HTML stays unique to MacroGenics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MGNX income, balance, and cash tables.